BD (Becton, Dickinson and Company)  a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance and Conformité Européenne (CE) ...

Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...

“The rapid expansion of PCR-based testing for both infectious and genetic diseases ... Food and Beverage, Consumer Technology ...

Closing rural diagnostic gap, HealthTrackRx delivers next-morning PCR test results nationwide to improve infection diagnosis and treatment.

World's largest TB prize illuminates Indian Molbio’s tech innovation reaching the unreached. By SHOBHA SHUKLA and BOBBY RAMAKANT ...

Abstract: This article investigates low-carbon technology (LCT) investment strategies within the electricity supply chain, employing a hybrid decision-making framework that considers both ...

Data from the dose optimization trial expected soon ProLectin-M is positioned as the first oral antiviral sugar chemistry drug BOSTON, ...

Co-Dx will equip the JV with an exclusive licence to utilise, produce, and market the licensed intellectual property.

Co-Diagnostics, Inc. (NASDAQ:CODX) announced on Monday that it has entered into a joint venture agreement with the Kingdom of ...

Co-Diagnostics shares are trading higher Monday after the company signed a definitive agreement to establish CoMira ...

Diagnostics' products, including its in-development point-of-care molecular diagnostics system, in Saudi Arabia and 18 other MENA countries.